Assessing the ‘Added Value’ of European Policy on New Psychoactive Substances

International Journal of Drug Policy - Netherlands
doi 10.1016/j.drugpo.2016.11.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

New Psychoactive Substances in Ireland Following the Criminal Justice (Psychoactive Substances) Act-Why All the Pessimism?

Addiction
MedicinePsychiatryMental Health
2017English

Novel Psychoactive Substances

2013English

Methylone and Pentylone: Structural Analysis of New Psychoactive Substances

Forensic Toxicology
BiochemistryForensic MedicinePathologyToxicology
2019English

Pharmacological Profile of Mephedrone Analogs and Related New Psychoactive Substances

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2018English

Psychiatric Aspects of Designer Drugs and New Psychoactive Substances Consumption

Interactive science
2017English

Exploring the Policy Dimensions of Trade in Value-Added

SSRN Electronic Journal
2014English

Mysterious Wave of Severe Poisonings in Poland by New Psychoactive Substances

Journal of Gerontology & Geriatric Research
2016English

An Overview of Recent Developments in the Analytical Detection of New Psychoactive Substances (NPSs)

Analyst, The
BiochemistryEnvironmental ChemistryAnalytical ChemistryElectrochemistrySpectroscopy
2015English

The Problem of Routing of Patients Using Psychoactive Substances

Kazan medical journal
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy